Treatment of Relapsed/Refractory AML-Novel Treatment Options Including Immunotherapy. Moore CG, Stein A, Fathi AT, Pullarkat V, et al. Am J Hematol 2025;100 Suppl 2:23-37.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moore CG, Stein A, Fathi AT, Pullarkat V, et al. Treatment of Relapsed/Refractory AML-Novel Treatment Options Including Immunotherapy. Am J Hematol 2025;100 Suppl 2:23-37.
PMID: 39960017